Trial intelligence / Profile preview

Combined Effect of Withania Somnifera and Syzygium Cumini on Hyperlipidemic Patients

NCT07578857Completed

Sponsor
Riphah International University
Start
May 2023
Primary completion
Oct 2023
Countries
1
01

Overview

Randomised trial in hyperlipidemia (4 arms), sponsored by Riphah International University. Primary endpoint: Improvement in Lipid Profile at 3 months. Started May 2023; status: completed.

02

Conditions

hyperlipidemia

Beyond the preview

Go deeper on NCT07578857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07578857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call